MentionFox
Home › funding signals › AOA Dx
Accelerator · announced

AOA Dx (YC S21) — Blood test for early detection of ovarian cancer

AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.

AOA Dx is a Y Combinator company in the Summer 2021 batch. Its directory entry describes it as: Blood Test for Early Detection of Ovarian Cancer. The founders listed are Oriana Papin-Zoghbi (Founder), Alex Fisher (Founder/COO), Anna Jeter (Founder) (Y Combinator directory entry, June 21, 2021).

6 more companies from YC Summer 2021 ↓

Run the free check on AOA Dx →

Sell to companies like AOA Dx? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

AOA Dx

New accelerator entry · 2021-06-21 · the record

Summer 2021
batch
25
people
Early
stage
United States of America
region
Open the record →

What the record says

BatchSummer 2021
Announced2021-06-21
StageEarly
StatusActive
Team size25
IndustryHealthcare
Sub-industryHealthcare -> Diagnostics
SectorsHealthcare, Diagnostics, Women's Health
RegionsUnited States of America, America / Canada, Remote, Partly Remote
BasedDenver, CO
HiringNo
Sitehttps://www.aoadx.com/
Founded2020
YC group partnerJared Friedman
Previously known asAOA Dx Inc.

Pitching, partnering or investing alongside them? See who really runs and owns AOA Dx.

Free to see. No signup.

Keep reading

More on AOA Dx and the records around it.

Also in YC Summer 2021

Same batch, Healthcare first.

What do you want to do with AOA Dx?

Get the full cited report on AOA Dx

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on AOA Dx: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

In their words

AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.

Want the whole picture on AOA Dx?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on AOA Dx: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on AOA Dx covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind AOA Dx: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.

Sourced from the company's Y Combinator directory entry.

RSS

Tools for this story

Each opens in a new tab, filled in for AOA Dx. With no account yet, you sign up free and land on the result.

On these startup lists

Healthcare and health tech startups Biotech startups

Share this page

Is this your company?

Share the news. Sharing needs no account.

AOA Dx: Accepted into Y Combinator Summer 2021
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/yc-aoa-dx-inc
Last updated 2026-10-30
Primary record: Y Combinator directory entry
AOA Dx (YC S21) — Blood test for early detection of ovarian cancer. MentionFox, 2026-10-30. https://mentionfox.com/funding/yc-aoa-dx-inc